Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
883 INR | -0,06 % | +4,78 % | +36,13 % |
09.04. | Strides Pharma Science erhält grünes Licht der US FDA für Fluoxetin-Tabletten | MT |
30.01. | Transcript : Strides Pharma Science Limited, Q3 2024 Earnings Call, Jan 30, 2024 |
Kurzporträt
Mitarbeiterzahl: 2 850
Umsatz nach Geschäftsbereich
INR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 30 703 | 100,0 % | 36 884 | 100,0 % | +20,13 % |
Umsatz je Region
INR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
North America
52,2
%
| 12 059 | 39,3 % | 19 261 | 52,2 % | +59,73 % |
Europe
22,7
%
| 6 769 | 22,0 % | 8 370 | 22,7 % | +23,66 % |
Africa
12,2
%
| 5 707 | 18,6 % | 4 506 | 12,2 % | -21,05 % |
Australia
8,4
%
| 3 175 | 10,3 % | 3 116 | 8,4 % | -1,86 % |
Global
2,2
%
| 482 | 1,6 % | 807 | 2,2 % | +67,49 % |
Asia (excluding India)
1,2
%
| 1 971 | 6,4 % | 461 | 1,2 % | -76,63 % |
India
0,6
%
| 473 | 1,5 % | 219 | 0,6 % | -53,82 % |
Others
0,4
%
| 67 | 0,2 % | 144 | 0,4 % | +115,54 % |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Arun N. Kumar
CEO | Chief Executive Officer | 63 | 28.06.90 |
Badree Komandur
DFI | Director of Finance/CFO | - | 01.02.10 |
Compliance Officer | - | 03.02.17 | |
Corporate Officer/Principal | - | 01.10.22 | |
Amit Gupta
AUD | Comptroller/Controller/Auditor | - | - |
Rj Ramesh
TRE | Treasurer | - | - |
Sormistha Ghosh
LAW | General Counsel | - | - |
Corporate Officer/Principal | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Arun N. Kumar
CEO | Chief Executive Officer | 63 | 28.06.90 |
Director/Board Member | 80 | 18.05.17 | |
Director/Board Member | 63 | 27.07.12 | |
Director/Board Member | 77 | 25.07.14 | |
Director/Board Member | 62 | 01.02. | |
Badree Komandur
DFI | Director of Finance/CFO | - | 01.02.10 |
Director/Board Member | 56 | 11.12.19 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 91 899 714 | 62 756 717 ( 68,29 %) | 0 | 68,29 % |
Unternehmenskontakt
Strides Pharma Science Ltd.
Strides House Bannerghatta Road
560076, Bangalore
+91 80 6784 0000
http://www.strides.comKonzerngesellschaften
Name | Kategorie und Branche |
---|---|
Strides Pharma UK Ltd.
Strides Pharma UK Ltd. Medical DistributorsDistribution Services Strides Pharma UK Ltd. engages in the acquisition, development, marketing and distribution of a wide range of generic medicines and other over the counter products. It provides anti emetic, histamine, infective spasticity medicines, cardiovascular, dental, dermatology, diuretics, nasal, lubricants, and steroids medicines. The company was founded in 1993 and is headquartered in Watford, the United Kingdom. |
Medical Distributors
|
Strides Pharma Global Pte Ltd.
Strides Pharma Global Pte Ltd. Pharmaceuticals: MajorHealth Technology Strides Pharma Global Pte Ltd. manufactures and distributes pharmaceutical products. The company was founded in 2013 and is headquartered in Singapore. |
Pharmaceuticals: Major
|
Strides Pharma, Inc.
Strides Pharma, Inc. Pharmaceuticals: MajorHealth Technology Strides Pharma, Inc. manufactures and distributes pharmaceutical products. The firm operates through the following brand name: JointFlex, Pedia Care, and NiteThru. The company is headquartered in Lambertville, NJ. |
Pharmaceuticals: Major
|
Vivimed Life Sciences Pvt Ltd.
Vivimed Life Sciences Pvt Ltd. Pharmaceuticals: MajorHealth Technology Vivimed Life Sciences Pvt Ltd. provides pharmaceutical services. The joint venture company is based in Hyderabad, India and was founded in 2017. |
Pharmaceuticals: Major
|
Arco Lab Pvt Ltd.
Arco Lab Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Strides Pharma Science Ltd., Arco Lab Pvt Ltd. is a private company based in Bengaluru, India. |
Miscellaneous Commercial Services
|
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
Verlauf des Gewinns je Aktie
Quartalsumsätze - Abweichungsrate
% 1. Jan. | Kap. | |
---|---|---|
+36,13 % | 975 Mio. | |
+20,44 % | 21,89 Mrd. | |
+13,23 % | 14,45 Mrd. | |
+13,31 % | 13,63 Mrd. | |
+37,85 % | 11,49 Mrd. | |
-8,59 % | 6,85 Mrd. | |
-0,05 % | 6,79 Mrd. | |
-8,87 % | 5,73 Mrd. | |
+6,35 % | 5,06 Mrd. | |
-5,36 % | 4,66 Mrd. |
- Börse
- Aktien
- A0DJ79 Aktie
- Unternehmen Strides Pharma Science Limited